Patents Assigned to Research Corporation Tech., Inc.
  • Patent number: 6162925
    Abstract: The present invention is directed to anti-bacterial and anti-tumor agents and the synthesis thereof.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: December 19, 2000
    Assignee: Research Corporation Tech., Inc.
    Inventors: Robert M. Williams, Chenguang Yuan
  • Patent number: 6057116
    Abstract: Methods and compositions are provided for detecting antigens having a specific epitope associated with melanoma and prostatic carcinoma. The epitope is present in melanoma cells and prostatic cancer cells but is essentially absent from melanocytes and normal prostatic tissue. The antibody can be used in diagnostic methods for histochemical detection of human melanoma and prostate carcinoma, of various progression stages and in treatment of melanoma and prostate carcinoma.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: May 2, 2000
    Assignee: Research Corporation Tech., Inc.
    Inventor: Juergen R. Vielkind
  • Patent number: 6048899
    Abstract: The present invention is directed to N-benzyl-2-amino-3-methoxypropionamide and stereoisomers the use thereof anti-convulsant and an intermediate in the preparation of other anti-convulsants.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: April 11, 2000
    Assignee: Research Corporation Tech., Inc.
    Inventors: Harold Kohn, Shridhar V. Andurkar
  • Patent number: 5880158
    Abstract: The present invention is directed to a compound of the following formula: ##STR1## pharmaceutical compositions containing the same and the use thereof as an anticonvulsant.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: March 9, 1999
    Assignee: Research Corporation Tech., Inc.
    Inventor: Harold Kohn
  • Patent number: 5767103
    Abstract: The present invention describes a method of sequestering nitric oxide from the bloodstream, endothelium or tissues of mammals by administering a cobalamin to such mammals. A method of treating diseases characterized by elevated nitric oxide levels in the bloodstream, endothelium or tissues is further provided. In particular, a method of treating sepsis by administering a therapeutic dose of hydroxocobalamin is described by the present invention. A method of alleviating systemic hypotension in a septic patient is further described by this invention. A pharmaceutical composition comprising a cobalamin in a concentration ranging from 0.5 to 50 mg composition/Kg body weight for mammals and is also provided.
    Type: Grant
    Filed: April 19, 1995
    Date of Patent: June 16, 1998
    Assignee: Research Corporation Tech., Inc.
    Inventors: Stanley S. Greenberg, Jianming Xie, Mark J. S. Miller, Judith Zatarian-Kuebel
  • Patent number: 5698675
    Abstract: This invention relates to a process for forming an amide or an ester from a reaction between an amine or an alcohol, respectively and an acylating derivative of a carboxylic acid, in the presence of an effective amount of a compound having the formula: ##STR1## and N-oxides thereof and salts thereof.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 16, 1997
    Assignee: Research Corporation Tech., Inc.
    Inventor: Louis A. Carpino
  • Patent number: 5656621
    Type: Grant
    Filed: February 15, 1994
    Date of Patent: August 12, 1997
    Assignee: Research Corporation Tech., Inc.
    Inventors: Arthur G. Schwartz, Marvin Louis Lewbart
  • Patent number: 5616605
    Abstract: This invention is directed to a collagenase inhibitor of the formula: ##STR1##
    Type: Grant
    Filed: August 8, 1994
    Date of Patent: April 1, 1997
    Assignee: Research Corporation Tech., Inc.
    Inventors: Robert D. Gray, Arno F. Spatola, Krzysztof Darlak
  • Patent number: 5589725
    Abstract: Monolithic, internally asymmetrically stress biased electrically active ceramic devices and a method for making same is disclosed. The first step in the method of the present invention is to fabricate a ceramic element having first and second opposing surfaces. Next, only the first surface is chemically reduced by heat treatment in a reducing atmosphere. This produces a concave shaped, internally asymmetrically stress biased ceramic element and an electrically conducting, chemically reduced layer on the first surface which serves as one of the electrodes of the device. Another electrode can be deposited on the second surface to complete the device. In another embodiment of the present invention two dome shaped ceramic devices can be placed together to form a completed clamshell structure or an accordion type structure. In a further embodiment, the clamshell or accordion type structures can be placed on top of one another.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: December 31, 1996
    Assignee: Research Corporation Tech., Inc.
    Inventor: Gene H. Haertling
  • Patent number: 5562925
    Abstract: Malignant tumors in animals are treated by parenterally administering to an affected animal a solution containing a complex compound of platinum in an amount effective to cause regression of the tumor.
    Type: Grant
    Filed: June 2, 1994
    Date of Patent: October 8, 1996
    Assignee: Research Corporation Tech. Inc.
    Inventors: Barnett Rosenberg, Loretta Vancamp, Thomas Krigas
  • Patent number: 5157020
    Abstract: Disclosed herein is a synthetic senescent cell antigen comprised of purified peptides immunoreactive with antibodies to the naturally occurring antigen. Preferably, the synthetic senescent cell antigen comprises two peptides with the amino acid sequences SKLIKIFQDHPLQKTYN and LFKPPKYHPDVPYVKR, respectively. The antigen and peptides may be used in compositions, diagnostic kits, and methods for detecting or measuring antibodies to senescent cell antigen, studying cellular aging and autoimmune mechanisms, separating anions from a gas or liquid, or treating certain diseases.
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: October 20, 1992
    Assignee: Research Corporation Tech., Inc.
    Inventors: Marguerite M. B. Kay, John J. Marchalonis